Anti-KIR2DL3 + KIR2DL1 + KIR2DL2 antibody [EPR22541-47]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal KIR2DL1 antibody. Suitable for Flow Cyt, WB, IHC-P and reacts with Human, Recombinant fragment - Human samples. Cited in 1 publication.
View Alternative Names
CD158a, CD158A, NKAT1, KIR2DL1, Killer cell immunoglobulin-like receptor 2DL1, CD158 antigen-like family member A, Natural killer-associated transcript 1, p58 natural killer cell receptor clones CL-42/47.11, p58.1 MHC class-I-specific NK receptor, NKAT-1, p58 NK receptor CL-42/47.11
- Flow Cyt
Unknown
Flow Cytometry - Anti-KIR2DL3 + KIR2DL1 + KIR2DL2 antibody [EPR22541-47] (AB224697)
Flow cytometric analysis of human peripheral blood mononuclear cell (PBMC) cells labeling KIR2DL2+KIR2DL1+KIR2DL3 with ab224697 at 1/600 compared with a Rabbit monoclonal IgG (ab172730) / Left isotype control. Goat anti rabbit IgG (Alexa Fluor® 488, ab150097) at 1/5000 dilution was used as the secondary antibody. Cells were stained with rabbit IgG (Left) or ab224697 (Right). Then stained with anti-CD56 conjugated to BV421. Gated on viable cells.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KIR2DL3 + KIR2DL1 + KIR2DL2 antibody [EPR22541-47] (AB224697)
Immunohistochemical analysis of paraffin-embedded human endometrium tissue labeling KIR2DL2+KIR2DL1+KIR2DL3 with ab224697 at 1/500 dilution (1.13μg/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Positive staining in natural killer (NK) cells in human endometrium (PMID : 7749980). Counterstained with hematoxylin. Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
- WB
Supplier Data
Western blot - Anti-KIR2DL3 + KIR2DL1 + KIR2DL2 antibody [EPR22541-47] (AB224697)
Blocking and diluting buffer : 5% NFDM/TBST
The actual band size higher than predicted is mainly due to glycosylation.
The molecular weight observed is consistent with what has been described in the literatures
(PMID : 11454312 and PMID : 12370356).
All lanes:
Western blot - Anti-KIR2DL3 + KIR2DL1 + KIR2DL2 antibody [EPR22541-47] (ab224697) at 1/2000 dilution
All lanes:
HuT-78 (Human Sezary syndrome cutaneous T lymphocyte) whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 38-60 kDa
false
Exposure time: 40s
- WB
Lab
Western blot - Anti-KIR2DL3 + KIR2DL1 + KIR2DL2 antibody [EPR22541-47] (AB224697)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KIR2DL3 + KIR2DL1 + KIR2DL2 antibody [EPR22541-47] (ab224697) at 1/1000 dilution
Lane 1:
His-tagged human KIR2DL1 recombinant protein (aa1-245)
Lane 2:
His and LIF-tagged human KIR2DL2 recombinant protein (aa26-221)
Lane 3:
His-tagged human KIR2DL3 recombinant protein (aa1-245)
Lane 4:
His-tagged human KIR2DS1 recombinant protein (aa22-221)
Lane 5:
His-tagged human KIR2DS2 recombinant protein (aa22-221)
Lane 6:
His-tagged human KIR2DS3 recombinant protein (aa22-221)
Lane 7:
His-tagged human KIR2DS4 recombinant protein (aa22-221)
Lane 8:
His-tagged human KIR2DS5 recombinant protein (aa22-221) 20 ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 15s
Related conjugates and formulations (1)
-
Anti-KIR2DL3 + KIR2DL1 + KIR2DL2 antibody [EPR22541-47] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 12:6769 PubMed35474089
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com